Is there a high risk of transfusion for neonatal jaundice?

Is there a high risk of transfusion for neonatal jaundice?

1. Neonatal jaundice exchange transfusion therapy has certain risks, but not very large. If not treated in time, the condition will worsen and have a greater impact on the health of the newborn.

2. After serum bilirubin is formed in the body, it is transferred to the liver and excreted from the intestines with bile. When the newborn produces too much bilirubin or there are obstacles to transfer, intake, or treatment, the bilirubin concentration increases and jaundice will appear. Blood treatment is bleeding from the artery and transfusing blood into the vein. The purpose is to change excessive bilirubin, allergic red blood cells and antibodies, reduce blood bilirubin, and prevent the aggravation of bilirubin encephalopathy. There is a certain risk, but it is not large.

3. The risks of blood exchange therapy mainly lie in complications such as infection and hemolysis, but newborns who need blood exchange therapy usually have failed phototherapy, severe hemolysis or early bilirubin encephalopathy. If blood exchange is not timely, not only will jaundice not be controlled, but it may also endanger the life safety of the newborn.

4. Once neonatal jaundice occurs, careful care is required, such as insisting on breastfeeding, getting more sun exposure, observing the color of the fetal stool and skin condition, and seeking medical attention in time if there are any abnormalities.